Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer.
Neoplastic Cells, Circulating
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.
Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells.
A microfluidic device for label-free, physical capture of circulating tumor cell clusters.
MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.
HER2 expression identifies dynamic functional states within circulating breast cancer cells.
Expression of ß-globin by cancer cells promotes cell survival during blood-borne dissemination.
AR Expression in Breast Cancer CTCs Associates with Bone Metastases.
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy.
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer.
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis.
HIF1A signaling selectively supports proliferation of breast cancer in the brain.
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA.
Neoplastic Cells Circulating